Patients' perspectives on antiepileptic medication: Relationships between beliefs about medicines and adherence among patients with epilepsy in UK primary care

Epilepsy and Behavior

Volumn 31, Issue , 2014, Pages 312-320

  Chapman, S C E ^a   Horne, R ^a   Chater, A ^a   Hukins, D ^c   Smithson, W H ^b  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c YORK ST JOHN UNIVERSITY   (United Kingdom)

Author keywords

Antiepileptic drugs; Beliefs about Medicines Questionnaire (BMQ); Epilepsy; Medicine adherence; Perceived Sensitivity to Medicines (PSM) scale; Primary care

Indexed keywords

ANTICONVULSIVE AGENT;

ADULT; ARTICLE; ATTITUDE; BELIEF ABOUT MEDICINE QUESTIONNAIRE; CLINICAL ASSESSMENT TOOL; COMMUNITY SAMPLE; EPILEPSY; FEMALE; HEALTH BELIEF; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PERCEIVED SENSITIVITY TO MEDICINE SCALE; PERCEPTION; PRIMARY MEDICAL CARE; QUESTIONNAIRE; RISK FACTOR; SEIZURE; SELF REPORT; TREATMENT RESPONSE; UNITED KINGDOM; YOUNG ADULT;

ANTIEPILEPTIC DRUGS; BELIEFS ABOUT MEDICINES QUESTIONNAIRE (BMQ); EPILEPSY; MEDICINE ADHERENCE; PERCEIVED SENSITIVITY TO MEDICINES (PSM) SCALE; PRIMARY CARE;

ADULT; AGED; ANTICONVULSANTS; CULTURE; EPILEPSY; FEMALE; GREAT BRITAIN; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PERCEPTION; PRIMARY HEALTH CARE; SEVERITY OF ILLNESS INDEX;

EID: 84893014920     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2013.10.016     Document Type: Article

References (31)

1. Kwan P., Brodie M.J. Early identification of refractory epilepsy. N Engl J Med 2000, 342(5):314-319.
2. Meyer A.C., Dua T., Ma J., Saxena S., Birbeck G. Global disparities in the epilepsy treatment gap: a systematic review. Bull World Health Organ 2010, 88(4):260-266.
3. Crossley J., Jacoby A., Baker G.A. The reliability and validity of the Revised Liverpool Impact of Epilepsy Scale for use in people with new-onset epilepsy. Epilepsy Behav 2013, 26(2):175-181.
4. Burneo J.G., Jette N., Theodore W., Begley C., Parko K., Thurman D.J., et al. Disparities in epilepsy: report of a systematic review by the North American Commission of the International League Against Epilepsy. Epilepsia 2009, 50(10):2285-2295.
5. DiIorio C., Shafer P.O., Letz R., Henry T.R., Schomer D.L., Yeager K. Project EASE: a study to test a psychosocial model of epilepsy medication management. Epilepsy Behav 2004, 5(6):926-936.
6. Manjunath R., Davis K.L., Candrilli S.D., Ettinger A.B. Association of antiepileptic drug nonadherence with risk of seizures in adults with epilepsy. Epilepsy Behav 2009, 14(2):372-378.
7. Buelow J.M., Smith M.C. Medication management by the person with epilepsy: perception versus reality. Epilepsy Behav 2004, 5(3):401-406.
8. Chen H.F., Tsai Y.F., Lin Y.P., Shih M.S., Chen J.C. The relationships among medicine symptom distress, self-efficacy, patient-provider relationship, and medication compliance in patients with epilepsy. Epilepsy Behav 2010, 19(1):43-49.
9. Smithson W.H., Hukins D., Colwell B., Mathers N. Developing a method to identify medicines non-adherence in a community sample of adults with epilepsy. Epilepsy Behav 2012, 24(1):49-53.
10. Nakhutina L., Gonzalez J.S., Margolis S.A., Spada A., Grant A. Adherence to antiepileptic drugs and beliefs about medication among predominantly ethnic minority patients with epilepsy. Epilepsy Behav 2011, 22(3):584-586.
11. Kemp S., Feely M., Hay A., Wild H., Cooper C. Psychological factors and use of antiepileptic drugs: pilot work using an objective measure of adherence. Psychol Health Med 2007, 12(1):107-113.
12. Bautista R.E.D., Jain D. Detecting health disparities among Caucasians and African-Americans with epilepsy. Epilepsy Behav 2011, 20(1):52-56.
13. Bautista R.E.D., Gonzales W., Jain D. Factors associated with poor seizure control and increased side effects after switching to generic antiepileptic drugs. Epilepsy Res 2011, 95(1-2):158-167.
14. Horne R., Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999, 47(6):555-567.
15. Horne R., Chapman SCE, Freemantle N., Forbes A., Cooper V. Understanding patients' adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework. PLOS ONE 2013, [in press].
16. Horne R., Parham R., Driscoll R., Robinson A. Patients' attitudes to medicines and adherence to maintenance treatment in inflammatory bowel disease. Inflamm Bowel Dis 2009, 15(6):837-844.
17. Horne R., Faasse K., Cooper V., Diefenbach M.A., Leventhal H., Leventhal E., et al. The perceived sensitivity to medicines (PSM) scale: an evaluation of validity and reliability. Br J Health Psychol 2013, 18(1):18-30.
18. Horne R. Representations of medication and treatment: advances in theory and measurement. Perceptions of health and illness: current research and applications 1997, 155-188. Harwood Academic Publishers, London. K.J. Petrie, J. Weinman (Eds.).
19. Horne R. Treatment perceptions and self-regulation. The self-regulation of health and illness behaviour 2003, 138-153. Routledge, London. L.D. Cameron, H. Leventhal (Eds.).
20. Nunes V.D., Sawyer L., Neilson J., Sarri G., Cross J.H. Diagnosis and management of the epilepsies in adults and children: summary of updated NICE guidance. BMJ 2012, 344:e281.
21. Brown I., Sheeran P., Reuber M. Enhancing antiepileptic drug adherence: a randomized controlled trial. Epilepsy Behav 2009, 16(4):634-639.
22. Bautista R.E., Graham C., Mukardamwala S. Health disparities in medication adherence between African-Americans and Caucasians with epilepsy. Epilepsy Behav 2011, 22(3):495-498.
23. Smithson W.H., Hukins D. Identifying the strengths and weaknesses of epilepsy care in general practice - a case note review. Prim Health Care Res Dev 2008, 9(04):291-298.
24. Horne R., Weinman J., Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health 1999, 14(1):1-24.
25. Kahneman D. Thinking, fast and slow 2011, Farrar, Strauss and Giroux, New York.
26. Aikens J.E., Nease D.E., Nau D.P., Klinkman M.S., Schwenk T.L. Adherence to maintenance-phase antidepressant medication as a function of patient beliefs about medication. Ann Fam Med 2005, 3(1):23-30.
27. Andrade S.E., Kahler K.H., Frech F., Chan K.A. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf 2006, 15(8):565-574. [discussion 575-567].
28. Horne R., Buick D., Fisher M., Leake H., Cooper V., Weinman J. Doubts about necessity and concerns about adverse effects: identifying the types of beliefs that are associated with non-adherence to HAART. Int J STD AIDS 2004, 15(1):38-44.
29. Horne R. Compliance, adherence, and concordance: implications for asthma treatment. Chest 2006, 130(1 Suppl.):65S-72S.
30. Horne R., Graupner L., Frost S., Weinman J., Wright S.M., Hankins M. Medicine in a multi-cultural society: the effect of cultural background on beliefs about medications. Soc Sci Med 2004, 59(6):1307-1313.
31. Smithson W.H., Hukins D., Buelow J.M., Allgar V., Dickson J. Adherence to medicines and self-management of epilepsy: a community-based study. Epilepsy Behav 2013, 26(1):109-113.